ExodusPoint Capital Management’s Procept Biorobotics PRCT Stock Holding History

ExodusPoint Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Buy	+96,376	New	+$2.41M	0.01%	784
2026 Q1	–	Sell	-237,198	Closed	-$7.46M	–	1986
2025 Q4	$7.46M	Buy	+237,198	New	+$7.87M	0.06%	338
2025 Q3	–	Sell	-48,021	Closed	-$2.77M	–	1918
2025 Q2	$2.77M	Buy	+48,021	New	+$2.72M	0.02%	626
2023 Q2	–	Sell	-338,950	Closed	-$9.63M	–	2174
2023 Q1	$9.63M	Buy	+338,950	New	+$12M	0.08%	287
2022 Q2	–	Sell	-16,863	Closed	-$590K	–	2340
2022 Q1	$590K	Buy	+16,863	New	+$406K	0.01%	1439

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ExodusPoint Capital Management's PRCT Position: Q2 2026 in Review

ExodusPoint Capital Management opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 96,376 shares worth $2.18M. The stake represents 0.01% of the portfolio and ranks #784 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in PRCT as recently as Q4 2025.

ExodusPoint Capital Management first reported a position in PRCT in Q1 2022 and has held it in 5 quarters since. The position peaked at $9.63M in Q1 2023. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

ExodusPoint Capital Management held 96,376 shares of Procept Biorobotics worth $2.18M as of Q2 2026.
Procept Biorobotics was a new ExodusPoint Capital Management position in Q2 2026.
Procept Biorobotics made up 0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #784 holding.
ExodusPoint Capital Management first reported a position in Procept Biorobotics in Q1 2022 and has held it in 5 quarters since.
ExodusPoint Capital Management's Procept Biorobotics position peaked at $9.63M in Q1 2023.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.